FDA Defies RFK’s Pledge, Approves Moderna’s Risky Vaccine for Kids

Go to Article

Last Updated on July 10, 2025

The U.S. Food and Drug Administration granted full approval to Moderna’s COVID-19 vaccine, Spikevax, for children aged 6 months to 11 years at high risk, despite Health Secretary Robert F. Kennedy Jr.’s May 2025 directive against routine COVID vaccinations for healthy children, according to Reuters.

This decision contradicts Kennedy’s promise to prioritize American citizens’ safety. Previously under emergency use, Spikevax targets the JN.1 variant, with Moderna planning updates for the 2025-26 season.

Kennedy, a vaccine skeptic, replaced all 17 members of the CDC’s Advisory Committee on Immunization Practices with seven, including anti-vaccine advocates. Yet, the CDC recommends updated COVID vaccines for all aged six months and up, exposing a policy rift, per Reuters.

Alarming Adverse Events Ignored

The FDA’s approval of Moderna’s Spikevax, as reported by Reuters, overlooks significant safety concerns raised by prior data. The vaccine, previously under emergency use, carries risks that clash with Kennedy’s safety directives.

“Health secretary Robert F. Kennedy Jr. had in May said the U.S. has stopped recommending routine COVID-19 vaccinations for healthy children,” Reuters noted, highlighting the contradiction.

The U.S. Food and Drug Administration has granted full approval for Moderna’s COVID-19 vaccine, Spikevax, in children aged 6 months through 11 years who are at an increased risk of the disease, the company said on Thursday — Reuters

This approval, prioritizing Moderna’s interests, ignores the lack of placebo-controlled trials, as noted in ClinicalTrials.gov, obscuring true risks for America’s youngest citizens.

Dr. John Campbell’s Scathing Critique

Dr. John Campbell, a retired nurse educator with over 3 million YouTube subscribers, sharply criticized the FDA’s approval in a July 2025 video, calling it “bemusing.”

He emphasized the 2.7% serious adverse event rate and myocarditis risks, arguing these far outweigh benefits for low-risk children.

Moreover, Campbell highlighted that the vaccine’s lipid nanoparticles spread widely, potentially increasing harm. He also faulted the 8.8-month follow-up as too brief to evaluate long-term risks like cancer.

Furthermore, he expressed shock at the FDA’s dismissal of VAERS data, which shows a 118-fold higher adverse event rate compared to flu vaccines.

Finally, Campbell noted the vaccine’s reduced effectiveness in immunocompromised individuals, further weakening its case, per the FDA.



Public Condemns FDA’s Betrayal

Public reaction on X reflects widespread distrust, with many aligned with the Make America Healthy Again (MAHA) movement condemning the FDA’s decision.

Users captured this sentiment, stating, “FDA’s Moderna approval ignores RFK’s pledge, risking kids with myocarditis and 2.7% serious adverse events.”

This view, shared by MAHA supporters, highlights the perceived violation of Kennedy’s commitment to prioritize children’s safety over corporate interests.

A Blow to Trust in Institutions

The FDA’s decision, ignoring Kennedy’s pledge to halt unsafe vaccine policies, fuels distrust.

This undermines individual liberty and limited government, leaving parents questioning their children’s safety.



Comment on this Article Via Your Disqus Account